Home / Metformin and Dapagliflozin / Canada
CA ATC A10BD15 · updated 2 Nov 2026
Metformin and Dapagliflozin shortage in Canada
Is there a Metformin and Dapagliflozin shortage in Canada?
Yes. As of 2 Nov 2026, 4 Metformin and Dapagliflozin products are reported short in Canada, the first since 4 May 2026. The company estimate for the return is 4 Dec 2026 (latest 18 Dec 2026). Main reason: manufacturing problem.
Not reported short in any other country we track. All countries.
Affected products in Canada
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CA | APO-DAPAGLIFLOZIN-METFORMIN (60 BTL) limited | APOTEX INC | 4 May 2026 | 4 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DAPAGLIFLOZIN-METFORMIN (60 BTL) | APOTEX INC | 4 Sep 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DAPAGLIFLOZIN-METFORMIN (60 BTL) | APOTEX INC | 22 Sep 2026 | 18 Dec 2026 | Manufacturing problem Disruption of the manufacture of the drug |
| CA | APO-DAPAGLIFLOZIN-METFORMIN (60 BTL) | APOTEX INC | 25 Sep 2026 | not given | Manufacturing problem Disruption of the manufacture of the drug |
Source
Health Canada, Health Product Shortages Canada. Official list. Mandatory company reports since 2017: actual and anticipated shortages, plus products about to be discontinued.